FDA approves Reblozyl for anemia in beta thalassemia requiring regular RBC transfusions Nov. 11, 2019 No Comments
Initiation of phase Ib study of mavorixafor in severe congenital neutropenia Nov. 6, 2019 No Comments
BioCryst advances phase I study of BCX-9930 for paroxysmal nocturnal hemoglobinuria Oct. 29, 2019 No Comments
Grant supports clinical trial of personalized treatment approach for aplastic anemia Oct. 23, 2019 No Comments
RSS